SCHEMBL8501880

SCHEMBL8501880

Cc1ccc(C(=S)c2cccc(Cn3ncccc3=O)c2C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ IDO1 P14902 1/20 0.33
▸ P2RY14 Q15391 3/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ HTR2B P41595 1/20 0.32
▸ MRGPRX1 Q96LB2 1/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ TP53 P04637 1/20 0.32
▸ TBXAS1 P24557 1/20 0.31
▸ GPR139 Q6DWJ6 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ HCRTR1 O43613 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8504953 0.89 ALDH1A1 (0.38) ALDH1A1HPGDHTTNPSR1KDM4E
SCHEMBL8501881 0.70 ALDH1A1 (0.38) ALDH1A1HTTKDM4EMAPTMEN1
SCHEMBL28502249 0.69 ALDH1A1 (0.44) ALDH1A1HTTKDM4ETDP1IDO1
SCHEMBL8501886 0.68 NPBWR1 (0.45) NPSR1MAPTKMT2ATP53NPC1
SCHEMBL7581125 0.67 LMNA (0.36) ALDH1A1HPGDKDM4EMAPTMEN1
SCHEMBL8504945 0.67 NPBWR1 (0.39) ALDH1A1HPGDHTTNPSR1IDO1
SCHEMBL8502103 0.65 BDKRB1 (0.37) ALDH1A1HPGDHTTNPSR1KDM4E
SCHEMBL8526361 0.65 MAPT (0.43) ALDH1A1HTTNPSR1MAPTMEN1
SCHEMBL8504948 0.61 ALDH1A1 (0.37) ALDH1A1HTTKDM4EMAPTMEN1
SCHEMBL10633273 0.61 NPC1 (0.50) ALDH1A1HTTKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5886178-A ADMINISTERING OF A PROSTAGLANDIN G/H SYNTHASE INHIBITOR TO A PATIENT TO TREAT INFLAMMATORY OR AUTOIMMUNE DISEASES SYNTEX (U.S.A.) INC. (US) 1999-03-23 — — US disclosed
Send feedback